Developing a cost-effective imaging strategy, fully integrated into a broader clinical development process, requires specific knowledge of regulatory requirements and ever-changing industry trends. Our consulting services are lead by a team with over 25 combined years experience in the use of medical imaging in clinical trials. Additional world-class imaging consulting expertise is available through the worldwide RadMD network of over 600 physicians and imaging medical physicists.

When independent image evaluations ("blinded reads") are used in trials, it is critical that physicians performing the evaluations have expertise in the disease process. Our blinded reader sourcing service matches the most qualified physicians to individual studies, with the largest global network of physicians who have undergone standardized training as blinded readers. This translates into faster image evaluations by the most qualified personnel for your trials.
In the News
NOVEMBER 17, 2016
Kohkan Shamsi, MD, PhD Co-Authors "Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial"
read more
SEPTEMBER 13, 2016
Kohkan Shamsi, MD, PhD, presents "Imaging in Alzheimer's Disease Trials: Impact on Patient Recruitment, Retention and Logistics" at the 2016 Alzheimer's Association International Conference in Toronto, ON
read more
AUGUST 09, 2016
JAMA Article on Gadolinium Exposure and Parkinson's: A False Sense of Safety? ~Welk B, McArthur E, Marrow SA, et al. Association between Gadolinium contrast Exposure and the Risk of Parkinsonism. JAMA 2016;316:96-98
read more
JUNE 03, 2016
"Deposition of Gadolinium in After Multiple GBCA Injections: Clinical Trial Prospective" by Kohkan Shamsi, MD, PhD
read more
Who We Are Services BRITI News Contact Us
Consulting Sourcing BRITI